Leaps by Bayer, 6 Dimensions Capital and Alexandria Venture Investments are among the investors that have provided series A funding for the biomolecular medicine startup.

Partners Healthcare has resubscribed in the round, which included fellow corporates Gilead Sciences and Orient Life, increasing the long-lasting medicine developer's total funding to $78m.

Having emerged from the Merck Serono Entrepreneur Partnership Program (EPP) in 2015, Prexton Therapeutics raised a total $41m of funding before it was acquired by pharmaceutical firm Lundbeck for an estimated $1.1bn last year.

Shepherd Kaplan Krochuck and Molex Ventures have helped the epinephrine pen developer raise $12.1m of a funding round expected to close at $39m.

Greenoaks Capital has led a $500m funding round for Clover Health, a health insurance provider that last raised cash in a $130m GV-backed round in 2017.

US-based pension fund Lacera has provided $100m for the latest fund to be raised by corporate venturing unit Lilly Asia Ventures, which has a $750m target.

Existing backer SoftBank China was among the participants in a series E round that will support the expansion of Taimei Technology's clinical trial management platform.

Hana Ventures intends to provide some $890m in loans and direct investment for VC firms targeting biotech and ICT companies, over the next three years.

Rob Lavine, News editor for Global Corporate Venturing, reviews the trends in venturing from 2018

Indian Institute of Management, Ahmedabad joined Unitus Ventures and Axilor Ventures to supply seed capital to radiology directory 5C Network, which helps hospitals access radiology expertise.